miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease

Wu,Rongzhou; Shen,Danping; Sohun,Hareshwaree; Ge,Donghui; Chen,Xianda; Wang,Xuliang; Chen,Ruiyao; Wu,Yuqing; Zeng,Jingjing; Rong,Xing; Su,Xiaoping; Chu,Maoping

doi:10.3892/ijmm.2018.3397

miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease

Authors:
- Rongzhou Wu
- Danping Shen
- Hareshwaree Sohun
- Donghui Ge
- Xianda Chen
- Xuliang Wang
- Ruiyao Chen
- Yuqing Wu
- Jingjing Zeng
- Xing Rong
- Xiaoping Su
- Maoping Chu
View Affiliations

Affiliations: Children's Heart Center, Institute of Cardiovascular Development and Translational Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China
Published online on: January 18, 2018 https://doi.org/10.3892/ijmm.2018.3397
Pages: 1899-1908
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kawasaki disease (KD) is an acute, self‑limited vasculitis that predominantly affects medium‑sized arteries, particularly the coronary arteries. Recent studies have indicated that microRNAs are involved in many diseases, including KD. However, the detailed mechanism remains unclear. The aim of the present study was to explore the role of miR‑186 in KD and potentially discover a new target for KD treatment. The results demonstrated that miR‑186 was upregulated in serum from patients with KD and KD serum could increase miR‑186 transcript levels in endothelial cells (HUVECs). Overexpression of miR‑186 mimic induced HUVEC apoptosis through mitogen‑activated protein kinase (MAPK) activation by targeting and inhibiting SMAD family member 6 (SMAD6). Furthermore, KD serum induced HUVEC apoptosis through miR‑186. In conclusion, the present results suggested that KD serum‑associated miR‑186 has an essential role in endothelial cell apoptosis by activating the MAPK pathway through targeting the SMAD6 gene.

View Figures

View References

1	Newburger JW, Takahashi M and Burns JC: Kawasaki Disease. J Am Coll Cardiol. 67:1738–1749. 2016. View Article : Google Scholar : PubMed/NCBI
2	Gordon JB, Kahn AM and Burns JC: When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol. 54:1911–1920. 2009. View Article : Google Scholar : PubMed/NCBI
3	Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G and Yamakawa R: Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 94:1379–1385. 1996. View Article : Google Scholar : PubMed/NCBI
4	Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 324:1633–1639. 1991. View Article : Google Scholar : PubMed/NCBI
5	Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW and Pober JS: Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 2:1298–1302. 1989. View Article : Google Scholar : PubMed/NCBI
6	Amano S, Hazama F and Hamashima Y: Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J. 43:633–643. 1979. View Article : Google Scholar : PubMed/NCBI
7	Arkin A: A Clinical and pathological study of periarteritis nodosa: A report of five cases, one histologically healed. Am J Pathol. 6:401–426.5. 1930.PubMed/NCBI
8	Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, et al: Cardiovascular status after Kawasaki disease in the UK. Heart. 101:1646–1655. 2015. View Article : Google Scholar : PubMed/NCBI
9	Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H and Yoshibayashi M: A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 167:249–258. 2014. View Article : Google Scholar : PubMed/NCBI
10	Liang M: MicroRNA: A new entrance to the broad paradigm of systems molecular medicine. Physiol Genomics. 38:113–115. 2009. View Article : Google Scholar : PubMed/NCBI
11	Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
12	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
13	Yun KW, Lee JY, Yun SW, Lim IS and Choi ES: Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease. Pediatr Cardiol. 35:745–752. 2014. View Article : Google Scholar
14	Shimizu C, Kim J, Stepanowsky P, Trinh C, Lau HD, Akers JC, Chen C, Kanegaye JT, Tremoulet A, Ohno-Machado L and Burns JC: Differential expression of miR-145 in children with Kawasaki disease. PLoS One. 8:e581592013. View Article : Google Scholar : PubMed/NCBI
15	Rowley AH, Pink AJ, Reindel R, Innocentini N, Baker SC, Shulman ST and Kim KY: A study of cardiovascular miRNA biomarkers for Kawasaki disease. Pediatr Infect Dis J. 33:1296–1299. 2014. View Article : Google Scholar : PubMed/NCBI
16	Rong X, Jia L, Hong L, Pan L, Xue X, Zhang C, Lu J, Jin Z, Qiu H, Wu R and Chu M: Serum miR-92a-3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions. J Cardiovasc Transl Res. 10:1–8. 2017. View Article : Google Scholar
17	He M, Chen Z, Martin M, Zhang J, Sangwung P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC and Shyy JY: miR-483 targeting of CTGF suppresses endothelial-to-mesenchymal transition: Therapeutic implications in Kawasaki disease. Circ Res. 120:354–365. 2017. View Article : Google Scholar :
18	Chu M, Wu R, Qin S, Hua W, Shan Z, Rong X, Zeng J, Hong L, Sun Y, Liu Y, et al: Bone marrow-derived microRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease. J Am Heart Assoc. 6:pii: e0048782017. View Article : Google Scholar
19	Cao C, Sun D, Zhang L and Song L: miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1. Oncotarget. 7:79956–79963. 2016. View Article : Google Scholar : PubMed/NCBI
20	Dong Y, Jin X, Sun Z, Zhao Y and Song X: MiR-186 inhibited migration of NSCLC via targeting cdc42 and effecting EMT process. Mol Cells. 40:195–201. 2017.PubMed/NCBI
21	McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, et al: Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American heart association. Circulation. 135:e927–e999. 2017. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C T method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Higashi K, Terai M, Hamada H, Honda T, Kanazawa M and Kohno Y: Impairment of angiogenic activity in the serum from patients with coronary aneurysms due to Kawasaki disease. Circ J. 71:1052–1059. 2007. View Article : Google Scholar : PubMed/NCBI
24	Tian J, Lv HT, An XJ, Ling N and Xu F: Endothelial microparticles induce vascular endothelial cell injury in children with Kawasaki disease. Eur Rev Med Pharmacol Sci. 20:1814–1818. 2016.PubMed/NCBI
25	He JH, Han ZP, Zou MX, Wang L, Lv YB, Zhou JB, Cao MR and Li YG: Analyzing the LncRNA, miRNA, and mRNA regulatory network in prostate cancer with bioinformatics software. J Comput Biol. 2017.Epub ahead of print. PubMed/NCBI
26	Yang JH, Li JH, Shao P, Zhou H, Chen YQ and Qu LH: starBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 39:D202–D209. 2011. View Article : Google Scholar
27	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
28	Vlachos IS, Paraskevopoulou MD, Karagkouni D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL, Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0: Indexing more than half a million experimentally supported miRNA: mRNA interactions. Nucleic Acids Res. 43:D153–D159. 2015. View Article : Google Scholar
29	Jung SM, Lee JH, Park J, Oh YS, Lee SK, Park JS, Lee YS, Kim JH, Lee JY, Bae YS, et al: Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun. 4:25622013. View Article : Google Scholar
30	Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM and Derynck R: TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26:3957–3967. 2007. View Article : Google Scholar : PubMed/NCBI
31	Hua X, Xiao Y, Pan W, Li M, Huang X, Liao Z, Xian Q and Yu L: miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3. Am J Cancer Res. 6:1650–1660. 2016.PubMed/NCBI
32	Liu Z, Zhang G, Yu W, Gao N and Peng J: miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1. Biochem Biophys Res Commun. 469:692–697. 2016. View Article : Google Scholar
33	Wang KJ, Zhao X, Liu YZ, Zeng QT, Mao XB, Li SN, Zhang M, Jiang C, Zhou Y, Qian C, et al: Circulating miR-19b-3p, miR-134-5p and miR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem. 38:1015–1029. 2016. View Article : Google Scholar : PubMed/NCBI
34	Davignon J and Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation. 109(Suppl 1): III27–III32. 2004. View Article : Google Scholar : PubMed/NCBI
35	Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, et al: Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol. 34:790–800. 2014. View Article : Google Scholar : PubMed/NCBI
36	Hartopo AB and Setianto BY: Coronary artery sequel of Kawasaki disease in adulthood, a concern for internists and cardiologists. Acta Med Indones. 45:69–75. 2013.PubMed/NCBI
37	Li Z, Jiang J, Tian L, Li X, Chen J, Li S, Li C and Yang Z: A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs. PLoS One. 12:e01754072017. View Article : Google Scholar : PubMed/NCBI
38	Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G and Egido J: TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 74:196–206. 2007. View Article : Google Scholar : PubMed/NCBI
39	Liu C, Chen F, Han X, Xu H and Wang Y: Role of TGF-β1/p38 MAPK pathway in hepatitis B virus-induced tubular epithelial-myofibroblast transdifferentiation. Int J Clin Exp Pathol. 7:7923–7930. 2014.
40	Wei J, Li Z, Chen W, Ma C, Zhan F, Wu W and Peng Y: AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation. Cell Biol Int. 37:1016–1021. 2013. View Article : Google Scholar : PubMed/NCBI
41	Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK and Arya DS: Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK/NF-κB/TNF-α and TGF-β1/MAPK/fibronectin pathways. Am J Physiol Renal Physiol. 2:F414–F422. 2017. View Article : Google Scholar
42	Hyman KM, Seghezzi G, Pintucci G, Stellari G, Kim JH, Grossi EA, Galloway AC and Mignatti P: Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery. 132:173–179. 2002. View Article : Google Scholar : PubMed/NCBI
43	Ferrari G, Terushkin V, Wolff MJ, Zhang X, Valacca C, Poggio P, Pintucci G and Mignatti P: TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38 (MAPK) from the prosurvival p38β to proapoptotic p38α. Mol Cancer Res. 10:605–614. 2012. View Article : Google Scholar : PubMed/NCBI
44	Pollman MJ, Naumovski L and Gibbons GH: Vascular cell apoptosis: Cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation. 99:2019–2026. 1999. View Article : Google Scholar : PubMed/NCBI
45	Tsukada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Matsuoka N, Takashima H, Mizokami A and Nagataki S: Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun. 210:1076–1082. 1995. View Article : Google Scholar : PubMed/NCBI
46	Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW, et al: Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 4:16–25. 2011. View Article : Google Scholar
47	Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A and Burns JC: The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol. 44:189–198. 2013. View Article : Google Scholar